Larimar Therapeutics (LRMR) Shares Issued (2016 - 2020)
Historic Shares Issued for Larimar Therapeutics (LRMR) over the last 6 years, with Q4 2020 value amounting to $242000.0.
- Larimar Therapeutics' Shares Issued fell 9299.57% to $242000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $18.1 million, marking a year-over-year decrease of 666.19%. This contributed to the annual value of $161.8 million for FY2024, which is 53925333.33% up from last year.
- Per Larimar Therapeutics' latest filing, its Shares Issued stood at $242000.0 for Q4 2020, which was down 9299.57% from -$135000.0 recorded in Q3 2020.
- In the past 5 years, Larimar Therapeutics' Shares Issued registered a high of $64.2 million during Q3 2018, and its lowest value of -$135000.0 during Q3 2020.
- Over the past 5 years, Larimar Therapeutics' median Shares Issued value was $261000.0 (recorded in 2018), while the average stood at $6.0 million.
- In the last 5 years, Larimar Therapeutics' Shares Issued skyrocketed by 8016625.0% in 2018 and then tumbled by 10135.69% in 2020.
- Larimar Therapeutics' Shares Issued (Quarter) stood at $165000.0 in 2016, then crashed by 51.52% to $80000.0 in 2017, then skyrocketed by 275.0% to $300000.0 in 2018, then skyrocketed by 1051.67% to $3.5 million in 2019, then plummeted by 93.0% to $242000.0 in 2020.
- Its Shares Issued was $242000.0 in Q4 2020, compared to -$135000.0 in Q3 2020 and $8.4 million in Q2 2020.